reported a related finding, describing a similar latency to sleep induction behavior in DSIP-abnormal subjects
Orforglipron could hit shelves in 2026, and Eli Lilly has already ramped up its production Eli Lilly told Business Insider that the company is already manufacturing orforglipron pills to ensure it can meet demand ASAP if and when the drug is approved for use in the US
Parlato S, Santini SM, Lapenta C, Di Pucchio T, Logozzi M, Spada M, et al
Your clinician will likely evaluate: Your Primary Goal: Is the focus blood sugar control, weight loss, or both
Discuss all risks and benefits with your doctor, especially if you are pregnant, breastfeeding, or have a history of heart, kidney, or electrolyte disorders